Dr Nathalie Dang
Dr Nathalie Dang
Nathalie is Medical Director for Europe at ViiV Healthcare, a pharmaceutical company 100% dedicated to HIV.
Nathalie spent a number of years in medical communication and then joined Pfizer as the senior Medical Manager for Europe, responsible for medical strategy development, phase IIIB/IV clinical plans and investigator initiated research for maraviroc, the first in class CCR5 inhibitor.
Nathalie has an MD from Paris VII Xavier-Bichat University, a Master of Strategy and a degree in Statistics. Nathalie is a French national.
Nathalie co-chairs the UK Board of Trustees of the charity.